NASDAQ:VRDN News 15 December 2025

Viridian Therapeutics stock jumps to a 52-week high as VRDN traders zero in on June FDA deadline

Viridian Therapeutics shares jumped 6.4% to a 52-week high Wednesday, defying a broader market decline. The move comes as investors await the FDA’s June 30 decision on veligrotug for thyroid eye disease. Viridian was valued near $3.1 billion and reported $888 million in cash as of October.

14 January 2026

Biotechnology·NASDAQ:VRDN·Pharmaceuticals

Viridian Therapeutics, Inc. (VRDN) Stock Surges on Dec. 15, 2025: Latest News, Analyst Forecasts, and 2026 Catalysts

Viridian Therapeutics, Inc. stock (Nasdaq: VRDN) is back in the spotlight on December 15, 2025, as shares push to fresh highs amid a mix of sector news, new Wall Street coverage, and a shifting competitive landscape in thyroid eye disease (TED)—the company’s core focus. As of 9:47 a.m. ET (14:47 UTC), VRDN stock traded at $33.84, up about 4.7% on the day, after touching an intraday high of $34.92. That move extends a strong multi-month run and underscores how quickly sentiment can change around late-stage biotech names when the market smells a cleaner path to commercialization. VRDN stock today: price

15 December 2025

Biotechnology·NASDAQ:VRDN·Stock Market

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

7 February 2026

Wells Fargo shares rose 2.63% to $93.97 Friday as U.S. stocks rebounded. The stock traded ex-dividend for a $0.45 payout due March 1. Investors await delayed U.S. jobs and inflation data next week and a scheduled CFO appearance at a bank conference.

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

7 February 2026

Merck shares closed up 1.8% at $121.93 Friday after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140. Insider filings showed three executives sold shares this week. Merck’s stock ended just below its 52-week high, with about 13 million shares traded.

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026

Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.

HSBC share price bounces back after BoE split vote — what to watch before Feb 25 results

7 February 2026

HSBC shares closed up 2.2% at £13.06 on Friday, reversing Thursday’s drop as traders weighed possible Bank of England rate cuts and awaited the bank’s annual results on Feb. 25. The FTSE 100 rose 0.6%, with major UK banks also gaining. HSBC is also preparing to cut some banker bonuses and push out underperformers amid a cost reset. Key UK, U.S., and euro zone economic data are due next week.

NASDAQ:VRDN News 15 December 2025 - 14 January 2026

Viridian Therapeutics stock jumps to a 52-week high as VRDN traders zero in on June FDA deadline

Viridian Therapeutics, Inc. (VRDN) Stock Surges on Dec. 15, 2025: Latest News, Analyst Forecasts, and 2026 Catalysts

Stock Market Today

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

HSBC share price bounces back after BoE split vote — what to watch before Feb 25 results